optimizing adjuvant treatment of early breast cancer: where are we today?
Published 3 weeks ago • 2 plays • Length 27:11Download video MP4
Download video MP3
Similar videos
-
1:00
defining optimal therapy in high-risk early breast cancer #shorts
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer
-
1:15:47
evolving landscape of hr-positive metastatic breast cancer: a year in review
-
1:19
optimizing adjuvant therapy: chemotherapy necessity in hr-positive breast cancer
-
24:30
s1 episode 4: managing lung cancer with neoadjuvant and adjuvant therapy
-
36:48
outcome in mind: applying best practices for managing hr /her2- ebc at high risk of recurrence
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
0:59
dr. muss on optimizing adjuvant treatment for older breast cancer patients
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
-
46:31
adjuvant therapy | 2023 best of breast conference
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
1:03:44
new & supporting data for optimizing therapy in her2 breast cancer | dr. meisel & dr. soliman
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
22:48
adjuvant therapy of breast cancer
-
4:02
assessment of short preoperative endocrine therapy in the adapt and adaptcycle trials